Tocagen Stock Price - TOCA

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 0.62 ▲ 0.02 (4.08%)
Company Name Stock Ticker Symbol Market Type
Tocagen Inc TOCA NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.0051 -0.85% 0.5957 0.61 0.58 0.60 0.6008 23:59:44
Bid Price Ask Price Spread Spread % News
0.10 1.00 0.90 90.0% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
514 134,765 $ 0.5918116 $ 79,755 333,640 0.53 - 14.75
Last Trade Time Type Quantity Stock Price Currency
17:54:01 formt 100 $ 0.62 USD

Tocagen Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 14.24M 23.90M $ -48.96M -2.45 - 23.43M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 11.00 2.00%

more financials information »

Tocagen News

Loading Messages....

Latest TOCA Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TOCA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.65060.68770.580.6230956214,483-0.0549-8.44%
1 Month0.580.790.5615420.6543953261,5600.01572.71%
3 Months4.464.510.531.07831,657-3.86-86.64%
6 Months8.909.270.532.42550,072-8.30-93.31%
1 Year11.8514.750.534.46388,481-11.25-94.97%
3 Years10.2717.95280.537.40249,184-9.67-94.2%
5 Years10.2717.95280.537.40249,184-9.67-94.2%

Tocagen Description

Tocagen Inc is a clinical-stage, cancer-selective gene therapy company. It is focused on developing product candidates designed to activate a patient's immune system against their own cancer from within. The company's cancer-selective gene therapy platform is built on retroviral replicating vectors, or RRVs, which are designed to selectively deliver therapeutic genes into the DNA of cancer cells. Tocagen is developing product candidate, Toca 511 and Toca FC, for the treatment of recurrent high grade glioma, or HGG, a brain cancer with limited treatment options, low survival rates and, therefore, a significant unmet medical need. Geographically, the activities are carried out through United States.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.